MOH — authorised 1 September 2022
- Marketing authorisation holder: BOEHRINGER INGELHEIM PHARMACEUTICALS INC
- Status: likely_approved
🇮🇱 Spevigo in Israel
MOH authorised Spevigo on 1 September 2022
Marketing authorisation
Spevigo in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Immunology approved in Israel
Frequently asked questions
Is Spevigo approved in Israel?
Yes. MOH authorised it on 1 September 2022.
Who is the marketing authorisation holder for Spevigo in Israel?
BOEHRINGER INGELHEIM PHARMACEUTICALS INC holds the Israeli marketing authorisation.